CPG
XPH icon

Custom Portfolio Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Custom Portfolio Group’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$16.3K Hold
410
– – 0.01% 147
2024
Q1 		$17.7K Hold
410
– – 0.01% 146
2023
Q4 		$17.1K Buy
+410
New +$15.5K 0.02% 145

Other funds holding XPH

CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
EH
Equitable Holdings New York $16.7B AUM 24.23% 1-Year Est. Return
KWM
Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
Envestnet Portfolio Solutions
Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Custom Portfolio Group's XPH Position: Q2 2024 in Review

Custom Portfolio Group held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q2 2024 at 410 shares worth $16.3K. The position accounts for 0.01% of the portfolio, ranked #147.

Custom Portfolio Group first reported a position in XPH in Q4 2023 and has held it in 3 quarters since. The position peaked at $17.7K in Q1 2024. 71 funds tracked by Wall St. Rank hold XPH as of Q2 2024.

  • Custom Portfolio Group held 410 shares of State Street SPDR S&P Pharmaceuticals ETF worth $16.3K as of Q2 2024.
  • Custom Portfolio Group left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q2 2024.
  • State Street SPDR S&P Pharmaceuticals ETF made up 0.01% of Custom Portfolio Group's portfolio in Q2 2024, its #147 holding.
  • Custom Portfolio Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2023 and has held it in 3 quarters since.
  • Custom Portfolio Group's State Street SPDR S&P Pharmaceuticals ETF position peaked at $17.7K in Q1 2024.
  • 71 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2024.

Based on Custom Portfolio Group's 13F filing for Q2 2024, filed 27 Aug 2024.